Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Castle Creek Pharmaceuticals
Sort By
Newest First
1 / 1
1 / 1
M&A
Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire Fibrocell
Castle Creek Pharmaceuticals, LLC
PR-M09-19-NI-044
Sep 18, 2019
Investment
Castle Creek Pharma Raises Funding to Repurpose Diacerein
Nice Insight
PAO-M10-18-NI-030
Oct 29, 2018
Treatment
Castle Creek Pharmaceuticals Receives FDA Fast Track Designation for Diacerein 1% Ointment for Treatment of Epidermolysis Bullosa Simplex
Castle Creek Pharmaceuticals
PR-M08-18-NI-120
Aug 31, 2018
Clinical Research
Castle Creek Pharmaceuticals Announces Data Validating First Investigator's Global Assessment Scale for Epidermolysis Bullosa Simplex Clinical Research
Castle Creek Pharmaceuticals
PR-M01-18-NI-065
Jan 22, 2018
